MGRX (Mangoceuticals) ROE % Adjusted to Book Value : -126.69% (As of Dec. 2024)

View and export this data going back to 2023. Start your Free Trial

What is Mangoceuticals ROE % Adjusted to Book Value?

Mangoceuticals's ROE % for the quarter that ended in Dec. 2024 was -57.01%. Mangoceuticals's PB Ratio for the quarter that ended in Dec. 2024 was 0.45. Mangoceuticals's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2024 was -126.69%.

Mangoceuticals ROE % Adjusted to Book Value Historical Data

The historical data trend for Mangoceuticals's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mangoceuticals ROE % Adjusted to Book Value Chart

Mangoceuticals Annual Data

Trend

Dec21

Dec22

Dec23

Dec24

ROE % Adjusted to Book Value

-173.39

-347.88

Mangoceuticals Quarterly Data
	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
ROE % Adjusted to Book Value	Get a 7-Day Free Trial								-126.08	-	-232.19	-104.91	-126.69

Competitive Comparison of Mangoceuticals's ROE % Adjusted to Book Value

For the Health Information Services subindustry, Mangoceuticals's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Mangoceuticals's ROE % Adjusted to Book Value Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Mangoceuticals's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Mangoceuticals's ROE % Adjusted to Book Value falls into.

Mangoceuticals ROE % Adjusted to Book Value Calculation

Mangoceuticals's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2024 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	-118.28%	/	0.34
	=	-347.88%

Mangoceuticals's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2024 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	-57.01%	/	0.45
	=	-126.69%

Mangoceuticals ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Mangoceuticals's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.

Mangoceuticals Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Mangoceuticals Inc (NAS:MGRX) » Definitions » ROE % Adjusted to Book Value

Comparable Companies

Traded in Other Exchanges

N/A

Address

15110 N. Dallas Parkway, Suite 600, Dallas, TX, USA, 75248

Website

https://www.mangoceuticals.com

Mangoceuticals Inc focuses on developing, marketing, and selling a variety of men's wellness products and services through a telemedicine platform. The platform provides access for customers to a licensed pharmacy for online fulfillment and distribution of certain medications that may be prescribed as part of telehealth consultations, including Mango ED products.

Executives

Alex P. Hamilton	director	26 LOOP ROAD, BEDFORD NY 10506
Amanda Elizabeth Hammer	officer: Chief Operating Officer	5128 GADSDEN AVENUE, KELLER TX 76244
Jacob D. Cohen	director, 10 percent owner, officer: CEO	2101 GLENDALE DRIVE, PLANO TX 75023
Tiger Cub Trust	10 percent owner	19 RYDDINGTON PL, DALLAS TX 75230
Kenny Myers	director	5101 ADDISON CIRCLE,, UNIT 401,, ADDISON TX 75001
Lorraine Pamela D'alessio	director	8200 WILSHIRE BLVD, BEVERLY HILLS, CALIFORNIA CA 90211
Eugene M Johnston	officer: CFO	PO BOX 669047, CHARLOTTE NC 28266
Jonathan Arango	director, officer: President, COO and Secretary	15110 DALLAS PARKWAY, SUITE 600, DALLAS TX 75248